nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Thiotepa—sarcoma	0.153	0.202	CbGbCtD
Tolvaptan—ABCB1—Dactinomycin—sarcoma	0.123	0.162	CbGbCtD
Tolvaptan—ABCB1—Mitoxantrone—sarcoma	0.11	0.145	CbGbCtD
Tolvaptan—ABCB1—Vincristine—sarcoma	0.0757	0.0996	CbGbCtD
Tolvaptan—ABCB1—Etoposide—sarcoma	0.0694	0.0913	CbGbCtD
Tolvaptan—CYP3A4—Mitoxantrone—sarcoma	0.0659	0.0868	CbGbCtD
Tolvaptan—ABCB1—Doxorubicin—sarcoma	0.0473	0.0623	CbGbCtD
Tolvaptan—CYP3A4—Vincristine—sarcoma	0.0454	0.0597	CbGbCtD
Tolvaptan—CYP3A4—Etoposide—sarcoma	0.0416	0.0547	CbGbCtD
Tolvaptan—CYP3A4—Doxorubicin—sarcoma	0.0283	0.0373	CbGbCtD
Tolvaptan—Vaginal haemorrhage—Thiotepa—sarcoma	0.00403	0.0168	CcSEcCtD
Tolvaptan—Hyperuricaemia—Thiotepa—sarcoma	0.00321	0.0134	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Thiotepa—sarcoma	0.00315	0.0131	CcSEcCtD
Tolvaptan—Blood uric acid increased—Thiotepa—sarcoma	0.00303	0.0126	CcSEcCtD
Tolvaptan—Prothrombin level increased—Epirubicin—sarcoma	0.00293	0.0122	CcSEcCtD
Tolvaptan—Hyperuricaemia—Vincristine—sarcoma	0.00285	0.0119	CcSEcCtD
Tolvaptan—Hyperuricaemia—Mitoxantrone—sarcoma	0.00277	0.0115	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Mitoxantrone—sarcoma	0.00272	0.0113	CcSEcCtD
Tolvaptan—Prothrombin level increased—Doxorubicin—sarcoma	0.00271	0.0113	CcSEcCtD
Tolvaptan—Respiratory failure—Vincristine—sarcoma	0.00269	0.0112	CcSEcCtD
Tolvaptan—Blood uric acid increased—Vincristine—sarcoma	0.00269	0.0112	CcSEcCtD
Tolvaptan—Blood uric acid increased—Mitoxantrone—sarcoma	0.00262	0.0109	CcSEcCtD
Tolvaptan—Hyperkalaemia—Mitoxantrone—sarcoma	0.00253	0.0105	CcSEcCtD
Tolvaptan—Urine output increased—Vincristine—sarcoma	0.00239	0.00994	CcSEcCtD
Tolvaptan—Ecchymosis—Mitoxantrone—sarcoma	0.00233	0.00968	CcSEcCtD
Tolvaptan—Hyperuricaemia—Etoposide—sarcoma	0.00231	0.0096	CcSEcCtD
Tolvaptan—Hypernatraemia—Epirubicin—sarcoma	0.00228	0.0095	CcSEcCtD
Tolvaptan—Polyuria—Vincristine—sarcoma	0.00218	0.00909	CcSEcCtD
Tolvaptan—Blood uric acid increased—Etoposide—sarcoma	0.00218	0.00907	CcSEcCtD
Tolvaptan—Hypernatraemia—Doxorubicin—sarcoma	0.00211	0.00879	CcSEcCtD
Tolvaptan—Blood creatinine increased—Thiotepa—sarcoma	0.00203	0.00843	CcSEcCtD
Tolvaptan—Dehydration—Thiotepa—sarcoma	0.00201	0.00837	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00195	0.00811	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00193	0.00805	CcSEcCtD
Tolvaptan—Hyponatraemia—Vincristine—sarcoma	0.00193	0.00802	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00191	0.00794	CcSEcCtD
Tolvaptan—Hyponatraemia—Mitoxantrone—sarcoma	0.00188	0.00781	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.00187	0.00778	CcSEcCtD
Tolvaptan—Dehydration—Vincristine—sarcoma	0.00178	0.00742	CcSEcCtD
Tolvaptan—Blood creatinine increased—Mitoxantrone—sarcoma	0.00175	0.00728	CcSEcCtD
Tolvaptan—Dehydration—Mitoxantrone—sarcoma	0.00174	0.00723	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Vincristine—sarcoma	0.00173	0.00719	CcSEcCtD
Tolvaptan—Hyperglycaemia—Thiotepa—sarcoma	0.00169	0.00702	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.00168	0.007	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00165	0.00686	CcSEcCtD
Tolvaptan—Renal failure—Thiotepa—sarcoma	0.00164	0.00682	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Epirubicin—sarcoma	0.00162	0.00675	CcSEcCtD
Tolvaptan—Vaginal haemorrhage—Doxorubicin—sarcoma	0.0015	0.00624	CcSEcCtD
Tolvaptan—Urinary tract disorder—Thiotepa—sarcoma	0.00148	0.00615	CcSEcCtD
Tolvaptan—Connective tissue disorder—Thiotepa—sarcoma	0.00147	0.00612	CcSEcCtD
Tolvaptan—Urethral disorder—Thiotepa—sarcoma	0.00147	0.00611	CcSEcCtD
Tolvaptan—Hyperglycaemia—Mitoxantrone—sarcoma	0.00146	0.00606	CcSEcCtD
Tolvaptan—Renal failure—Mitoxantrone—sarcoma	0.00142	0.00589	CcSEcCtD
Tolvaptan—Cardiac disorder—Thiotepa—sarcoma	0.00139	0.00578	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Etoposide—sarcoma	0.00137	0.0057	CcSEcCtD
Tolvaptan—Angiopathy—Thiotepa—sarcoma	0.00136	0.00565	CcSEcCtD
Tolvaptan—Immune system disorder—Thiotepa—sarcoma	0.00135	0.00563	CcSEcCtD
Tolvaptan—Mediastinal disorder—Thiotepa—sarcoma	0.00135	0.00561	CcSEcCtD
Tolvaptan—Urinary tract disorder—Vincristine—sarcoma	0.00131	0.00545	CcSEcCtD
Tolvaptan—Connective tissue disorder—Vincristine—sarcoma	0.0013	0.00543	CcSEcCtD
Tolvaptan—Malnutrition—Thiotepa—sarcoma	0.0013	0.00542	CcSEcCtD
Tolvaptan—Urethral disorder—Vincristine—sarcoma	0.0013	0.00541	CcSEcCtD
Tolvaptan—Hyperuricaemia—Epirubicin—sarcoma	0.00129	0.00538	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Epirubicin—sarcoma	0.00127	0.00528	CcSEcCtD
Tolvaptan—Cardiac disorder—Vincristine—sarcoma	0.00123	0.00513	CcSEcCtD
Tolvaptan—Blood uric acid increased—Epirubicin—sarcoma	0.00122	0.00509	CcSEcCtD
Tolvaptan—Angiopathy—Vincristine—sarcoma	0.0012	0.00501	CcSEcCtD
Tolvaptan—Pulmonary embolism—Epirubicin—sarcoma	0.0012	0.00499	CcSEcCtD
Tolvaptan—Ill-defined disorder—Dactinomycin—sarcoma	0.0012	0.00499	CcSEcCtD
Tolvaptan—Hyperuricaemia—Doxorubicin—sarcoma	0.0012	0.00498	CcSEcCtD
Tolvaptan—Mediastinal disorder—Vincristine—sarcoma	0.0012	0.00498	CcSEcCtD
Tolvaptan—Hyperkalaemia—Epirubicin—sarcoma	0.00118	0.00491	CcSEcCtD
Tolvaptan—Renal failure—Etoposide—sarcoma	0.00118	0.0049	CcSEcCtD
Tolvaptan—Blood bilirubin increased—Doxorubicin—sarcoma	0.00117	0.00489	CcSEcCtD
Tolvaptan—Malaise—Dactinomycin—sarcoma	0.00117	0.00485	CcSEcCtD
Tolvaptan—Blood uric acid increased—Doxorubicin—sarcoma	0.00113	0.00471	CcSEcCtD
Tolvaptan—Pulmonary embolism—Doxorubicin—sarcoma	0.00111	0.00462	CcSEcCtD
Tolvaptan—Dysgeusia—Mitoxantrone—sarcoma	0.0011	0.00459	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.0011	0.00458	CcSEcCtD
Tolvaptan—Hyperkalaemia—Doxorubicin—sarcoma	0.00109	0.00454	CcSEcCtD
Tolvaptan—Discomfort—Dactinomycin—sarcoma	0.00109	0.00453	CcSEcCtD
Tolvaptan—Ecchymosis—Epirubicin—sarcoma	0.00108	0.00452	CcSEcCtD
Tolvaptan—Urinary tract disorder—Etoposide—sarcoma	0.00106	0.00442	CcSEcCtD
Tolvaptan—Urethral disorder—Etoposide—sarcoma	0.00105	0.00439	CcSEcCtD
Tolvaptan—Ill-defined disorder—Mitoxantrone—sarcoma	0.00104	0.00434	CcSEcCtD
Tolvaptan—Nervous system disorder—Thiotepa—sarcoma	0.00104	0.00434	CcSEcCtD
Tolvaptan—Skin disorder—Thiotepa—sarcoma	0.00103	0.0043	CcSEcCtD
Tolvaptan—Malaise—Mitoxantrone—sarcoma	0.00101	0.00422	CcSEcCtD
Tolvaptan—Anorexia—Thiotepa—sarcoma	0.00101	0.00422	CcSEcCtD
Tolvaptan—Anorexia—Dactinomycin—sarcoma	0.00101	0.00419	CcSEcCtD
Tolvaptan—Ecchymosis—Doxorubicin—sarcoma	0.001	0.00418	CcSEcCtD
Tolvaptan—Cardiac disorder—Etoposide—sarcoma	0.000998	0.00415	CcSEcCtD
Tolvaptan—Angiopathy—Etoposide—sarcoma	0.000975	0.00406	CcSEcCtD
Tolvaptan—Immune system disorder—Etoposide—sarcoma	0.000971	0.00404	CcSEcCtD
Tolvaptan—Mediastinal disorder—Etoposide—sarcoma	0.000969	0.00403	CcSEcCtD
Tolvaptan—Discomfort—Mitoxantrone—sarcoma	0.000946	0.00394	CcSEcCtD
Tolvaptan—Anaphylactic shock—Vincristine—sarcoma	0.000943	0.00392	CcSEcCtD
Tolvaptan—Nervous system disorder—Vincristine—sarcoma	0.000925	0.00385	CcSEcCtD
Tolvaptan—Decreased appetite—Thiotepa—sarcoma	0.000924	0.00385	CcSEcCtD
Tolvaptan—Anaphylactic shock—Mitoxantrone—sarcoma	0.000918	0.00382	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Thiotepa—sarcoma	0.000918	0.00382	CcSEcCtD
Tolvaptan—Decreased appetite—Dactinomycin—sarcoma	0.000917	0.00382	CcSEcCtD
Tolvaptan—Dysgeusia—Etoposide—sarcoma	0.000916	0.00381	CcSEcCtD
Tolvaptan—Renal impairment—Epirubicin—sarcoma	0.000915	0.00381	CcSEcCtD
Tolvaptan—Constipation—Thiotepa—sarcoma	0.000909	0.00378	CcSEcCtD
Tolvaptan—Shock—Mitoxantrone—sarcoma	0.000903	0.00376	CcSEcCtD
Tolvaptan—Anorexia—Vincristine—sarcoma	0.000899	0.00374	CcSEcCtD
Tolvaptan—Hypoglycaemia—Epirubicin—sarcoma	0.000893	0.00371	CcSEcCtD
Tolvaptan—Skin disorder—Mitoxantrone—sarcoma	0.000892	0.00371	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Epirubicin—sarcoma	0.000889	0.0037	CcSEcCtD
Tolvaptan—Feeling abnormal—Thiotepa—sarcoma	0.000876	0.00365	CcSEcCtD
Tolvaptan—Anorexia—Mitoxantrone—sarcoma	0.000875	0.00364	CcSEcCtD
Tolvaptan—Hyponatraemia—Epirubicin—sarcoma	0.000875	0.00364	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000871	0.00363	CcSEcCtD
Tolvaptan—Feeling abnormal—Dactinomycin—sarcoma	0.00087	0.00362	CcSEcCtD
Tolvaptan—Ill-defined disorder—Etoposide—sarcoma	0.000868	0.00361	CcSEcCtD
Tolvaptan—Renal impairment—Doxorubicin—sarcoma	0.000847	0.00352	CcSEcCtD
Tolvaptan—Malaise—Etoposide—sarcoma	0.000844	0.00351	CcSEcCtD
Tolvaptan—Body temperature increased—Thiotepa—sarcoma	0.000841	0.0035	CcSEcCtD
Tolvaptan—Body temperature increased—Dactinomycin—sarcoma	0.000834	0.00347	CcSEcCtD
Tolvaptan—Hypoglycaemia—Doxorubicin—sarcoma	0.000826	0.00344	CcSEcCtD
Tolvaptan—Loss of consciousness—Etoposide—sarcoma	0.000823	0.00342	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Doxorubicin—sarcoma	0.000823	0.00342	CcSEcCtD
Tolvaptan—Decreased appetite—Vincristine—sarcoma	0.00082	0.00341	CcSEcCtD
Tolvaptan—Blood creatinine increased—Epirubicin—sarcoma	0.000816	0.0034	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Vincristine—sarcoma	0.000814	0.00339	CcSEcCtD
Tolvaptan—Dehydration—Epirubicin—sarcoma	0.00081	0.00337	CcSEcCtD
Tolvaptan—Hyponatraemia—Doxorubicin—sarcoma	0.000809	0.00337	CcSEcCtD
Tolvaptan—Constipation—Vincristine—sarcoma	0.000806	0.00336	CcSEcCtD
Tolvaptan—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000806	0.00335	CcSEcCtD
Tolvaptan—Decreased appetite—Mitoxantrone—sarcoma	0.000798	0.00332	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Epirubicin—sarcoma	0.000796	0.00331	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000791	0.00329	CcSEcCtD
Tolvaptan—Discomfort—Etoposide—sarcoma	0.000787	0.00328	CcSEcCtD
Tolvaptan—Breast disorder—Epirubicin—sarcoma	0.000787	0.00328	CcSEcCtD
Tolvaptan—Constipation—Mitoxantrone—sarcoma	0.000785	0.00327	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000784	0.00326	CcSEcCtD
Tolvaptan—Hypersensitivity—Thiotepa—sarcoma	0.000783	0.00326	CcSEcCtD
Tolvaptan—Hypersensitivity—Dactinomycin—sarcoma	0.000778	0.00324	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000768	0.0032	CcSEcCtD
Tolvaptan—Anaphylactic shock—Etoposide—sarcoma	0.000764	0.00318	CcSEcCtD
Tolvaptan—Asthenia—Thiotepa—sarcoma	0.000763	0.00317	CcSEcCtD
Tolvaptan—Asthenia—Dactinomycin—sarcoma	0.000757	0.00315	CcSEcCtD
Tolvaptan—Feeling abnormal—Mitoxantrone—sarcoma	0.000757	0.00315	CcSEcCtD
Tolvaptan—Blood creatinine increased—Doxorubicin—sarcoma	0.000755	0.00314	CcSEcCtD
Tolvaptan—Pruritus—Thiotepa—sarcoma	0.000752	0.00313	CcSEcCtD
Tolvaptan—Dehydration—Doxorubicin—sarcoma	0.00075	0.00312	CcSEcCtD
Tolvaptan—Body temperature increased—Vincristine—sarcoma	0.000745	0.0031	CcSEcCtD
Tolvaptan—Skin disorder—Etoposide—sarcoma	0.000742	0.00309	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Doxorubicin—sarcoma	0.000736	0.00306	CcSEcCtD
Tolvaptan—Breast disorder—Doxorubicin—sarcoma	0.000728	0.00303	CcSEcCtD
Tolvaptan—Anorexia—Etoposide—sarcoma	0.000728	0.00303	CcSEcCtD
Tolvaptan—Diarrhoea—Thiotepa—sarcoma	0.000728	0.00303	CcSEcCtD
Tolvaptan—Body temperature increased—Mitoxantrone—sarcoma	0.000726	0.00302	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000726	0.00302	CcSEcCtD
Tolvaptan—Diarrhoea—Dactinomycin—sarcoma	0.000722	0.00301	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000711	0.00296	CcSEcCtD
Tolvaptan—Dizziness—Thiotepa—sarcoma	0.000703	0.00293	CcSEcCtD
Tolvaptan—Pollakiuria—Epirubicin—sarcoma	0.000696	0.00289	CcSEcCtD
Tolvaptan—Hypersensitivity—Vincristine—sarcoma	0.000695	0.00289	CcSEcCtD
Tolvaptan—Hyperglycaemia—Epirubicin—sarcoma	0.000679	0.00283	CcSEcCtD
Tolvaptan—Hypersensitivity—Mitoxantrone—sarcoma	0.000677	0.00282	CcSEcCtD
Tolvaptan—Asthenia—Vincristine—sarcoma	0.000676	0.00282	CcSEcCtD
Tolvaptan—Headache—Thiotepa—sarcoma	0.000666	0.00277	CcSEcCtD
Tolvaptan—Decreased appetite—Etoposide—sarcoma	0.000664	0.00276	CcSEcCtD
Tolvaptan—Renal failure—Epirubicin—sarcoma	0.00066	0.00275	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Etoposide—sarcoma	0.000659	0.00274	CcSEcCtD
Tolvaptan—Asthenia—Mitoxantrone—sarcoma	0.000659	0.00274	CcSEcCtD
Tolvaptan—Constipation—Etoposide—sarcoma	0.000653	0.00272	CcSEcCtD
Tolvaptan—Diarrhoea—Vincristine—sarcoma	0.000645	0.00268	CcSEcCtD
Tolvaptan—Pollakiuria—Doxorubicin—sarcoma	0.000644	0.00268	CcSEcCtD
Tolvaptan—Nausea—Thiotepa—sarcoma	0.000632	0.00263	CcSEcCtD
Tolvaptan—Feeling abnormal—Etoposide—sarcoma	0.000629	0.00262	CcSEcCtD
Tolvaptan—Hyperglycaemia—Doxorubicin—sarcoma	0.000628	0.00262	CcSEcCtD
Tolvaptan—Diarrhoea—Mitoxantrone—sarcoma	0.000628	0.00261	CcSEcCtD
Tolvaptan—Nausea—Dactinomycin—sarcoma	0.000627	0.00261	CcSEcCtD
Tolvaptan—Dizziness—Vincristine—sarcoma	0.000623	0.00259	CcSEcCtD
Tolvaptan—Renal failure—Doxorubicin—sarcoma	0.000611	0.00254	CcSEcCtD
Tolvaptan—Body temperature increased—Etoposide—sarcoma	0.000604	0.00251	CcSEcCtD
Tolvaptan—Urinary tract disorder—Epirubicin—sarcoma	0.000595	0.00248	CcSEcCtD
Tolvaptan—Connective tissue disorder—Epirubicin—sarcoma	0.000592	0.00246	CcSEcCtD
Tolvaptan—Urethral disorder—Epirubicin—sarcoma	0.000591	0.00246	CcSEcCtD
Tolvaptan—Headache—Vincristine—sarcoma	0.000591	0.00246	CcSEcCtD
Tolvaptan—Headache—Mitoxantrone—sarcoma	0.000575	0.00239	CcSEcCtD
Tolvaptan—Hypersensitivity—Etoposide—sarcoma	0.000563	0.00234	CcSEcCtD
Tolvaptan—Nausea—Vincristine—sarcoma	0.00056	0.00233	CcSEcCtD
Tolvaptan—Cardiac disorder—Epirubicin—sarcoma	0.000559	0.00233	CcSEcCtD
Tolvaptan—Urinary tract disorder—Doxorubicin—sarcoma	0.000551	0.00229	CcSEcCtD
Tolvaptan—Asthenia—Etoposide—sarcoma	0.000548	0.00228	CcSEcCtD
Tolvaptan—Connective tissue disorder—Doxorubicin—sarcoma	0.000548	0.00228	CcSEcCtD
Tolvaptan—Angiopathy—Epirubicin—sarcoma	0.000547	0.00228	CcSEcCtD
Tolvaptan—Urethral disorder—Doxorubicin—sarcoma	0.000547	0.00227	CcSEcCtD
Tolvaptan—Nausea—Mitoxantrone—sarcoma	0.000545	0.00227	CcSEcCtD
Tolvaptan—Immune system disorder—Epirubicin—sarcoma	0.000544	0.00227	CcSEcCtD
Tolvaptan—Mediastinal disorder—Epirubicin—sarcoma	0.000543	0.00226	CcSEcCtD
Tolvaptan—Pruritus—Etoposide—sarcoma	0.00054	0.00225	CcSEcCtD
Tolvaptan—Malnutrition—Epirubicin—sarcoma	0.000525	0.00218	CcSEcCtD
Tolvaptan—Diarrhoea—Etoposide—sarcoma	0.000523	0.00217	CcSEcCtD
Tolvaptan—Cardiac disorder—Doxorubicin—sarcoma	0.000517	0.00215	CcSEcCtD
Tolvaptan—Dysgeusia—Epirubicin—sarcoma	0.000514	0.00214	CcSEcCtD
Tolvaptan—Angiopathy—Doxorubicin—sarcoma	0.000506	0.00211	CcSEcCtD
Tolvaptan—Dizziness—Etoposide—sarcoma	0.000505	0.0021	CcSEcCtD
Tolvaptan—Immune system disorder—Doxorubicin—sarcoma	0.000504	0.0021	CcSEcCtD
Tolvaptan—Mediastinal disorder—Doxorubicin—sarcoma	0.000503	0.00209	CcSEcCtD
Tolvaptan—Ill-defined disorder—Epirubicin—sarcoma	0.000487	0.00203	CcSEcCtD
Tolvaptan—Malnutrition—Doxorubicin—sarcoma	0.000485	0.00202	CcSEcCtD
Tolvaptan—Headache—Etoposide—sarcoma	0.000478	0.00199	CcSEcCtD
Tolvaptan—Dysgeusia—Doxorubicin—sarcoma	0.000475	0.00198	CcSEcCtD
Tolvaptan—Malaise—Epirubicin—sarcoma	0.000473	0.00197	CcSEcCtD
Tolvaptan—Syncope—Epirubicin—sarcoma	0.00047	0.00196	CcSEcCtD
Tolvaptan—Loss of consciousness—Epirubicin—sarcoma	0.000461	0.00192	CcSEcCtD
Tolvaptan—Nausea—Etoposide—sarcoma	0.000454	0.00189	CcSEcCtD
Tolvaptan—Ill-defined disorder—Doxorubicin—sarcoma	0.00045	0.00187	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000444	0.00185	CcSEcCtD
Tolvaptan—Discomfort—Epirubicin—sarcoma	0.000441	0.00184	CcSEcCtD
Tolvaptan—Malaise—Doxorubicin—sarcoma	0.000438	0.00182	CcSEcCtD
Tolvaptan—Dry mouth—Epirubicin—sarcoma	0.000437	0.00182	CcSEcCtD
Tolvaptan—Syncope—Doxorubicin—sarcoma	0.000435	0.00181	CcSEcCtD
Tolvaptan—Anaphylactic shock—Epirubicin—sarcoma	0.000428	0.00178	CcSEcCtD
Tolvaptan—Loss of consciousness—Doxorubicin—sarcoma	0.000427	0.00178	CcSEcCtD
Tolvaptan—Shock—Epirubicin—sarcoma	0.000421	0.00175	CcSEcCtD
Tolvaptan—Nervous system disorder—Epirubicin—sarcoma	0.00042	0.00175	CcSEcCtD
Tolvaptan—Skin disorder—Epirubicin—sarcoma	0.000416	0.00173	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00041	0.00171	CcSEcCtD
Tolvaptan—Discomfort—Doxorubicin—sarcoma	0.000408	0.0017	CcSEcCtD
Tolvaptan—Anorexia—Epirubicin—sarcoma	0.000408	0.0017	CcSEcCtD
Tolvaptan—Dry mouth—Doxorubicin—sarcoma	0.000404	0.00168	CcSEcCtD
Tolvaptan—Anaphylactic shock—Doxorubicin—sarcoma	0.000396	0.00165	CcSEcCtD
Tolvaptan—Shock—Doxorubicin—sarcoma	0.00039	0.00162	CcSEcCtD
Tolvaptan—Nervous system disorder—Doxorubicin—sarcoma	0.000388	0.00162	CcSEcCtD
Tolvaptan—Skin disorder—Doxorubicin—sarcoma	0.000385	0.0016	CcSEcCtD
Tolvaptan—Anorexia—Doxorubicin—sarcoma	0.000378	0.00157	CcSEcCtD
Tolvaptan—Decreased appetite—Epirubicin—sarcoma	0.000372	0.00155	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Epirubicin—sarcoma	0.00037	0.00154	CcSEcCtD
Tolvaptan—Constipation—Epirubicin—sarcoma	0.000366	0.00152	CcSEcCtD
Tolvaptan—Feeling abnormal—Epirubicin—sarcoma	0.000353	0.00147	CcSEcCtD
Tolvaptan—Decreased appetite—Doxorubicin—sarcoma	0.000344	0.00143	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000342	0.00142	CcSEcCtD
Tolvaptan—Constipation—Doxorubicin—sarcoma	0.000339	0.00141	CcSEcCtD
Tolvaptan—Body temperature increased—Epirubicin—sarcoma	0.000338	0.00141	CcSEcCtD
Tolvaptan—Feeling abnormal—Doxorubicin—sarcoma	0.000326	0.00136	CcSEcCtD
Tolvaptan—Hypersensitivity—Epirubicin—sarcoma	0.000315	0.00131	CcSEcCtD
Tolvaptan—Body temperature increased—Doxorubicin—sarcoma	0.000313	0.0013	CcSEcCtD
Tolvaptan—Asthenia—Epirubicin—sarcoma	0.000307	0.00128	CcSEcCtD
Tolvaptan—Pruritus—Epirubicin—sarcoma	0.000303	0.00126	CcSEcCtD
Tolvaptan—Diarrhoea—Epirubicin—sarcoma	0.000293	0.00122	CcSEcCtD
Tolvaptan—Hypersensitivity—Doxorubicin—sarcoma	0.000292	0.00121	CcSEcCtD
Tolvaptan—Asthenia—Doxorubicin—sarcoma	0.000284	0.00118	CcSEcCtD
Tolvaptan—Dizziness—Epirubicin—sarcoma	0.000283	0.00118	CcSEcCtD
Tolvaptan—Pruritus—Doxorubicin—sarcoma	0.00028	0.00117	CcSEcCtD
Tolvaptan—Diarrhoea—Doxorubicin—sarcoma	0.000271	0.00113	CcSEcCtD
Tolvaptan—Headache—Epirubicin—sarcoma	0.000268	0.00112	CcSEcCtD
Tolvaptan—Dizziness—Doxorubicin—sarcoma	0.000262	0.00109	CcSEcCtD
Tolvaptan—Nausea—Epirubicin—sarcoma	0.000254	0.00106	CcSEcCtD
Tolvaptan—Headache—Doxorubicin—sarcoma	0.000248	0.00103	CcSEcCtD
Tolvaptan—Nausea—Doxorubicin—sarcoma	0.000235	0.000979	CcSEcCtD
